The relationship between the immune system activity and the bacterial vaginosis development
Keywordsimmune system, bacterial vaginosis, pathogenic microbiota, system immune response, immunodeficiency
The main cause of bacterial vaginosis (BV) is immunodeficiency which is both systemic and local in nature and increases in parallel to a dysbiosis grade deepening. It is of great importance to link the indicators of BV-associated microbiota with individual indicators of systemic immune responses. The aim of the study is to establish a relationship between the immune system state and the development of various grades bacterial dysbiosis and BV. The study selected 298 women, who were divided into groups according to the index of conditionally pathogenic microflora (ICPM): in normocenosis ICPM was lower than -3 lg GE/sample (n = 53); in grade I dysbiosis it was from -3 to -1 lg GE/sample (n = 128); and in grade II dysbiosis (BV) it was more than -1 lg GE/sample (n = 117). Molecular-genetic studies of the scraping of epithelium from the posterolateral vaginal paries were performed using the method of polymerase chain reaction (DNA technology, RF). Optional and obligate anaerobes, myco- and ureplasms and yeast fungi were quantified. Content in the blood of fractions of T-and B-lymphocytes, immunoglobulins, cytokines, complement, lymphocyte phagocytic activity (LPA), 21 indicators in total) were determined using standard immunological methods. Interrelation between the microbial biocenosis with the considered indicators was studied using the regression analysis (Statistica 10; StatSoft, Inc.,USA).
In normocenosis, normobiota indicator (NBI) was determined by activation of complement (C4), PA – as well by activation of complement (C3) and by content of sIgA in blood; ObA and YF – by γ-INF level, and YF – also by IL8, IL10 and sIgA levels; ICPM effective value was determined by the number of CD22+ lymphocytes. In grade I dysbiosis, NBI depended on the number of CD22+ lymphocytes, IL6, IgM, IgG, LPI, CIC, IL10, which indicated the implementation of various mechanisms and involvement of almost all of the immune system levers to compensate for dysbiosis at the beginning of its formation. In grade I dysbiosis, ObA amount was also affected by IL6 and IL10, and MU amount – by IL1β and IgG. In grade II dysbiosis, no factors affected NBI, which indicated that the dysbiotic processes went beyond the control of the immune system. Content of IL1β in blood reflected a shift of the ICPM: when its level exceeded 24.6 pg/ml, grade II dysbiosis was present; at IL1β level from 9.6 pg/ml to 24.6 pg/ml – it was grade I dysbiosis, and at IL1β level less than 9.6 pg/ml – it was normocenosis. Factors, which anaerobic dysbiosis was the trigger for, were activation of the humoral immunity (IgG secretion) and IL10 increase.
General analysis of the interrelation between the immune system indicators with the number of pathogenic microbiota revealed the development of systemic combined immunodeficiency and “slipping” of the most pathogenic microorganisms out of the control of the immune system.
Kira E.F. Bacterial vaginosis. Moscow: Medical Information Agency, 2012. 472 p. [in Russian]
Bautista C.T., Wurapa E., Sateren W.B., Morris S., Hollingsworth B., Sanchez J.L. Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections. Mil Med Res. 2016; 3 (4). doi: 10.1186/s40779-016-0074-5.
Mark K.S., Tenorio B., Stennett C.A., Ghanem K.G., Brotman R.M. Bacterial vaginosis diagnosis and treatment in postmenFacAusal women: a survey of clinician practices. Menapause. 2020; 27(6): 679-683
Nasioudis D., Linhares I.M., Ledger W.J., Witkin S.S. Bacterial vaginosis: a critical analysis of current knowledge. BJOG. 2017; 124(1): 61-69.
van de Wijgert J.H.H.M., Jespers V. The global health impact of vaginal dysbiosis. Res Microbiol. 2017; 168(9-10): 859-864.
McKinnon L.R., Achilles S.L., Bradshaw C.S., Burgener A., Crucitti T., Fredricks D.N., Jaspan H.B., Kaul R. Kaushic C., Klatt N., Kwon D.S., Marrazzo J.M., Masson L., McClelland R.S., Ravel J., van de Wijgert J.H.H.M., Vodstrcil L.A., TachedjianG. The evolving facets of bacterial vaginosis: implications for HIV transmission. AIDS Res Hum Retroviruses. 2019; 35(3): 219-228.
Brusselaers N., Shrestha S., van de Wijgert J., Verstraelen H. Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis. Am J Obstet Gynecol. 2019; 221(1): 9-18.
Reid G. Is bacterial vaginosis a disease? Appl Microbiol Biotechnol. 2018; 102(2): 553-558.
Coudray M.S., Madhivanan P. Bacterial vaginosis – A brief synopsis of the literature. Eur J Obstet Gynecol Reprod Biol. 2020; 245: 143-148.
Muzny C.A., Taylor C.M., Swords W.E., Tamhane A., ChattFacAdhyay D., Cerca N., Schwebke J.R.. An updated conceptual model on the pathogenesis of bacterial vaginosis. J Infect Dis. 2019; 220(9): 1399-1405.
Ventolini G. Progresses in vaginal microflora physiology and implications for bacterial vaginosis and candidiasis. Womens Health (Lond). 2016; 12(3): 283-291.
Hickey R.J., Zhou X., Pierson J.D., Ravel J., Forney L.J. Understanding vaginal microbiome complexity from an ecological perspective. Transl Res. 2012; 160(4): 267-282.
Anderson D.J., Marathe J., Pudney J. The structure of the human vaginal stratum corneum and its role in immune defense. Am J Reprod Immunol. 2014; 71(6): 618-623.
Muzny C.A., Schwebke J.R. Pathogenesis of bacterial vaginosis: discussion of current hypotheses. J Infect Dis. 2016; 214(Suppl 1): 1-5.
Cox C., Watt A.P., McKenna J.P., Coyle P.V. Mycoplasma hominis and Gardnerella vaginalis display a significant synergistic relationship in bacterial vaginosis. Eur J Clin Microbiol Infect Dis. 2016; 35(3): 481-487.
Lipova E.V., Boldyreva M.N., Trofimov D.Yu., Vitvitskaya Yu.G. Femoflor. Urogenital infections caused by opportunistic biota in women of reproductive age (clinical and laboratory diagnostics). Manual for doctors. Moscow: DNA technology. 2015. 30 p. [in Russian]
Gruzevskyy OA, Vladymirova MP. [Results of a complex bacteriological study of vaginal contents under the conditions of bacterial vaginosis]. Ach biol and med. 2014;2:54-7. [in Ukrainian]
Gruzevskyy O.A.[Colonization resistance in vaginal dysbiosis: the state of humoral and cellular links. Bul Marine Med. 2017; 4(77):103-107. [in Russian]
Tits N.U. Encyclopedia of clinical laboratory tests. Moscow: Labinform. 1997. 960 p. [in Russian]
Delves P.J., Martin S.J., Burton D.R., Roitt I.M. Roitt's Essential Immunology, 13th Edition. 2016. Wiley-Blackwell, 576 p.
Gruzevskiy А.А. Colonization resistance of vaginal secretion. Journal of Education, Health and Sport. 2019; 9(2): 583-595.
Gruzevsky A.A., Zyablitsev S.V., Chernobrivtsev P.A. Frequency of vaginal conditional-pathogenic microflora dependency from age in conditions of normocenosis and disbiosis. Journal of Education, Health and Sport. 2017; 7(2): 509-522.
Kremleva E.A., Sgibnev A.V. Proinflammatory cytokines as regulators of vaginal microbiota. Bull Exp Biol Med. 2016; 162(1): 75-78.
Larsen J.M. The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology. 2017; 151(4): 363-374.
Anahtar M.N., Byrne E.H., Doherty K.E., Bowman B.A., Yamamoto H.S., Soumillon M., Padavattan N., Ismail N., Moodley A., Sabatini M.E., Ghebremichael M.S., Nusbaum C., Huttenhower C., Virgin H.W., Ndung'u T., Dong K.L., Walker B.D., Fichorova R.N., Kwon D.S. Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract. Immunity. 2015; 42(5): 965-976.
Hilbert D.W., Smith W.L., Paulish-Miller T.E., Chadwick S.G., Toner G., Mordechai E., Adelson M.E., Sobel J.D., Gygax S.E. Utilization of molecular methods to identify prognostic markers for recurrent bacterial vaginosis. Diagn Microbiol Infect Dis. 2016; 86(2): 231-242.
Onderdonk A.B., Delaney M.L., Fichorova R.N. The Human Microbiome during bacterial vaginosis. Clin Microbiol Rev. 2016; 29(2): 223-238.
Masson L., Barnabas S., Deese J., Lennard K., Dabee S., Gamieldien H., Jaumdally S.Z., Williamson A.L., Little F., Damme L.V., Ahmed K., Crucitti T., Abdellati S., Bekker L.-G., Gray G., Dietrich J., Jaspan H., Passmore Jo-Ann S. Inflammatory cytokine biomarkers of asymptomatic sexually transmitted infections and vaginal dysbiosis: a multicentre validation study. Sex Transm Infect. 2019; 95(1): 5-12.
Bertran T., Brachet P., Vareille-Delarbre M., Falenta J., Dosgilbert A., Vasson M.P., Forestier C., Tridon A., Evrard B.. Slight Pro-Inflammatory Immunomodulation Properties of Dendritic Cells by Gardnerella vaginalis: The "Invisible Man" of Bacterial Vaginosis? J Immunol Res. 2016; 2016:9747480. doi: 10.1155/2016/9747480.
van Teijlingen N.H., Helgers L.C., Zijlstra-Willems E.M., van Hamme J.L., Ribeiro C.M.S, Strijbis K., Geijtenbeek T.B.H. Vaginal dysbiosis associated-bacteria Megasphaera elsdenii and Prevotella timonensis induce immune activation via dendritic cells. J Reprod Immunol. 2020; 138: 103085. doi: 10.1016/j.jri.2020.103085.
How to Cite
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Number of views and downloads: 197
Number of citations: 0